Vital Signs with Jacob Effron and Nikhil Krishnan

Ep 24: Insitro CEO Daphne Koller on Using ML to Change Drug Discovery

Episode Summary

Jacob sits down with Insitro CEO Daphne Koller to discuss founding Coursera, where and how ML can drive the most impact in drug development, and if foundation models can transform core drug discovery work and edtech.

Episode Notes

Jacob sits down with Insitro CEO Daphne Koller to discuss founding Coursera, where and how ML can drive the most impact in drug development, and if foundation models can transform core drug discovery work and edtech.

00:00 intro

00:59 Daphne’s journey

09:02 AI and biology discovery

10:42 insitro vs. traditional pharma

19:47 phenotyping patients

25:44 early mistakes

29:34 the future of data

35:16 partnering with larger pharma companies

38:00 impact of LLMs on biopharma

43:47 over-hyped/under-hyped